These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22647554)

  • 1. Classification of inflammatory bowel disease: the old and the new.
    Vermeire S; Van Assche G; Rutgeerts P
    Curr Opin Gastroenterol; 2012 Jul; 28(4):321-6. PubMed ID: 22647554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic antiglycan antibodies in inflammatory bowel disease.
    Lakatos PL; Papp M; Rieder F
    Am J Gastroenterol; 2011 Mar; 106(3):406-12. PubMed ID: 21245832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity of phenotypic classification of inflammatory bowel disease.
    Louis E; Van Kemseke C; Reenaers C
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S2-7. PubMed ID: 21640927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic markers in inflammatory bowel disease (IBD).
    Nakamura RM; Barry M
    MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic biomarkers in inflammatory bowel disease].
    Kanmura S; Sakiyama T; Uto H; Tsubouchi H
    Nihon Rinsho; 2012 May; 70(5):790-5. PubMed ID: 22620002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of Montreal classification in different clinical and serological IBD subtypes.
    Mokrowiecka A; Kumor A; Jakubczyk E; Pietruczuk M; Malecka-Panas E
    Hepatogastroenterology; 2010; 57(101):787-93. PubMed ID: 21033230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis.
    Agius LM
    J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL; Abreu MT
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a novel molecular classification of IBD.
    Vermeire S
    Dig Dis; 2012; 30(4):425-7. PubMed ID: 22796810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoring systems in inflammatory bowel disease.
    Sehgal R; Koltun WA
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):513-21. PubMed ID: 20678023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic approach to IBD.
    Vermeire S; Peeters M; Rutgeerts P
    Hepatogastroenterology; 2000; 47(31):44-8. PubMed ID: 10690584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation into the validity of the present classification of inflammatory bowel disease.
    Holdstock G; Savage D; Harman M; Wright R
    Q J Med; 1985 Feb; 54(214):183-90. PubMed ID: 3983358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostics of inflammatory bowel disease.
    Nikolaus S; Schreiber S
    Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.